Water Vapor Ablation for Prostate Cancer Long-Term Registry
Part of Cancer, Kidney & urinary clinical trials.
This registry tracks the long-term effects of Vanquish, a water vapor therapy for prostate cancer. It's for people who are already getting or have gotten this treatment to see how well it works over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your doctor must have said you're a candidate for Vanquish therapy, or you've already finished a Vanquish study.
- You are willing and able to sign a written consent form.
- You must not have any medical reason that makes Vanquish unsafe for you (as listed in the device's instructions).
- You cannot have been in the VAPOR 2 study and decided not to get more Vanquish treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses water vapor (steam) to destroy a small, localized prostate cancer. The goal is to treat the cancer while possibly reducing side effects compared to removing the whole prostate.
This study collects information from men with prostate cancer who are having or have had a procedure to destroy prostate tumors (ablation). It aims to track outcomes over time to improve future treatments.
This trial checks the long-term safety (how it affects you over time) of lutetium-177 vipivotide tetraxetan in people with prostate cancer. You may be eligible if you already received the related drug in a prior Novartis prostate cancer study and can complete the required follow-up tests.
This trial tests a newer, more precise type of radiation therapy for intermediate-risk prostate cancer using micro-ultrasound guidance to target the tumor. It aims to shorten treatment and reduce side effects while maintaining effectiveness.
This trial tests a new treatment that uses water vapor (steam) to shrink an enlarged prostate. It may help men with bothersome urinary symptoms who have not had other prostate procedures.
This study tests a new water vapor treatment for men with a large prostate gland (80-120 ml) that is causing urinary symptoms. The treatment aims to shrink the prostate and improve urine flow without surgery.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.